<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05122923</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A00244-53</org_study_id>
    <nct_id>NCT05122923</nct_id>
  </id_info>
  <brief_title>Implementation of the S'TIM Serious-Game for Rehabilitation of Dysexecutive Disorders (S'TIM)</brief_title>
  <acronym>S'TIM 1</acronym>
  <official_title>Implementation of the S'TIM Serious-Game for Rehabilitation of Dysexecutive Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramsay Générale de Santé</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Clinical Trial Experts Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ramsay Générale de Santé</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study proposes to improve the management of dysexecutive syndrome by a serious game (SG)&#xD;
      in addition to the usual management including work in occupational therapy and&#xD;
      neuropsychology.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 3, 2020</start_date>
  <completion_date type="Anticipated">June 3, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 3, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The effect of using the serious-game S'TIM in terms of cognition</measure>
    <time_frame>6 weeks</time_frame>
    <description>TAP sub-test ERFC : overall cognitive functions BREF : presence or absence of a cognitive and / or behavioral dysexecutive syndrome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The effect of using the serious-game S'TIM at 6 weeks in terms of metacognition with the BRIEF-A</measure>
    <time_frame>6 weeks</time_frame>
    <description>Behaviour Rating Inventory of Executive Function, Adult</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The effect of using the serious-game S'TIM at 6 weeks in terms of behavior with BRIEF-A</measure>
    <time_frame>6 weeks</time_frame>
    <description>Behaviour Rating Inventory of Executive Function, Adult</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Dysexecutive Syndrome</condition>
  <condition>Serious Game</condition>
  <arm_group>
    <arm_group_label>Patients with Serious Game</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without Serious Game</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Serious Game S'TIM</intervention_name>
    <description>Video Game S'tim : the patient is inside a bedroom and he has to find a friend outside. this game will study the orientation, the memory of the patient</description>
    <arm_group_label>Patients with Serious Game</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  French-speaking male or female patient at least 18 years old&#xD;
&#xD;
          -  Patient suffering from recent disorders (less than 6 months) of executive functions&#xD;
&#xD;
          -  Patient with sufficient mobility of the upper limb (mobility of the dominant upper&#xD;
             limb greater than 70 °) to interact with the device.&#xD;
&#xD;
          -  Patient affiliated or beneficiary of a social security scheme&#xD;
&#xD;
          -  Patient having signed the free and informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient participating in another clinical study&#xD;
&#xD;
          -  Protected patient: adult under guardianship, curatorship or other legal protection,&#xD;
             deprived of liberty by judicial or administrative decision,&#xD;
&#xD;
          -  Pregnant or breastfeeding woman,&#xD;
&#xD;
          -  Patient hospitalized without consent.&#xD;
&#xD;
          -  Patient with unstable psychiatric disorders&#xD;
&#xD;
          -  Patient with comprehension disorders (alexia, visual agnosia, illiteracy, not&#xD;
             understanding the language, etc.)&#xD;
&#xD;
          -  Patient with executive function disorders greater than 6 months&#xD;
&#xD;
          -  Negligent hemi patient&#xD;
&#xD;
          -  Patient not familiar with the French language&#xD;
&#xD;
          -  Patient with major neuro-visual disorders.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-François Oudet</last_name>
    <phone>0683346567</phone>
    <email>jf.oudet@ecten.eu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Hélène Barba</last_name>
    <email>mh.barba@ecten.eu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinique de Provence Bourbonne</name>
      <address>
        <city>Aubagne</city>
        <zip>13400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michèle Timsit, Dr</last_name>
      <phone>06.15.31.10.22</phone>
      <email>m.timsit@ramsaygds.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 5, 2021</study_first_submitted>
  <study_first_submitted_qc>November 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

